Aguettant (Group)

https://www.aguettant.fr

o Family-owned pharmaceutical company based in Lyon, France o Sales over € 85 M over the past 12 months, of which more than 20% abroad o 3 development axis: o designing and industrialising innovative drug delivery systems for enhanced security in emergency medicine, o offering a range of essential micro-nutrients capable of preventing and curing critical deficiencies, o taking care of patients suffering from severe symptoms of Parkinson's disease. o Main project in progress: building a new R&D and manufacturing unit with the prospect of boosting innovation capabilities and enhancing international growth. *

	Start	2014-03-06 existent
	Industry	LIFE SCIENCES
	Person	Rougemond, Eric (Aguettant 201302– CEO)

	Region	Lyon
	Country	France
	Street	1 Rue Alexander Fleming
	City	69007 Lyon
	Tel	+33-4-7861-5141
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	85,000,000 (sales (last 12 months) 2012-09-30)

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Aguettant (Group)

[1] PX’Therapeutics S.A.. (2/20/19). "Press Release: 2019 – PX’Therapeutics Develops Its Services Offer"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com